Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4

Pulmofib 801mg Tablet

Prescription Icon
Prescription Required

Marketer

MSN Laboratories

Salt Composition

Pirfenidone (801mg)

Overview Pulmofib 801mg Tablet

Idiopathic pulmonary fibrosis (IPF) is treated with the prescription medication Pulmofib 801mg Tablet. This medication lessens lung inflammation and scarring, improving breathing capacity. For optimal results, take Pulmofib 801mg with food at the same time daily. Dosage and frequency are determined by your physician based on your individual needs. Continue taking the medication as prescribed. Common side effects include insomnia, headache, dizziness, indigestion, nausea, diarrhea, and sun sensitivity. To mitigate dizziness, avoid driving or activities requiring close attention. Weight loss is a potential side effect; regular weight monitoring or consultation with your doctor is advised. Your doctor may order liver function tests during treatment. Inform your physician of any existing liver or kidney conditions, as well as all other medications you're currently using, as interactions may affect Pulmofib's efficacy. Due to increased sun sensitivity, protective clothing and sunscreen are recommended during sun exposure. Disclose any pregnancy or breastfeeding to your doctor before commencing treatment.

Primary Ingredients of Pulmofib 801mg Tablet

The provided text is "undefined," which lacks meaning and cannot be rephrased.

Uses of Pulmofib 801mg Tablet

Managing idiopathic pulmonary fibrosis

Major Benefits of Pulmofib 801mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Pulmofib 801mg Tablet should be administered with a meal.

Common Side effects of Pulmofib 801mg Tablet:

  • Insomnia (difficulty in sleeping)
  • Headache
  • Dizziness
  • Tiredness
  • Sinus inflammation
  • Loss of appetite
  • Upper respiratory tract infection
  • Weight loss
  • Nausea
  • Indigestion
  • Diarrhea
  • Photosensitivity

How to use Pulmofib 801mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Pulmofib 801mg Tablet whole; do not break, crush, or chew it. Administer this medication with a meal.

How Pulmofib 801mg Tablet works:

Fibrosis-reducing Pulmofib 801mg tablets inhibit a specific endogenous compound implicated in lung scarring. This mechanism lessens pulmonary inflammation and fibrosis, thereby improving respiratory function.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Pulmofib 801mg Tablet may pose safety risks; seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Pulmofib 801mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Data on the use of Pulmofib 801mg tablets while breastfeeding is lacking. Seek medical advice from your physician.

DrivingDrivingUNSAFE

Taking a Pulmofib 801mg tablet might cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.

KidneyKidneyCAUTION

Exercise caution when administering 801mg Pulmofib tablets to individuals with impaired renal function; dosage modification may be necessary. Consult a physician for guidance. Pulmofib 801mg tablets are contraindicated for patients with severe kidney disease or those undergoing dialysis.

LiverLiverCAUTION

Patients with liver impairment should use Pulmofib 801mg tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. Pulmofib 801mg tablets are contraindicated in individuals with severe hepatic dysfunction.

What if you forget to take Pulmofib 801mg Tablet :

NA

Facts to Know About Pulmofib 801mg Tablet

LabelValue
Chemical Type Pyridone Derivative
Developing Habits No.
Treatment Category Breathing
Action Class Idiopathic pulmonary fibrosis (IPF)

FAQs on Pulmofib 801mg Tablet

Before starting Pulmofib 801mg Tablet treatment, your doctor will assess your liver function. This will be monitored monthly for six months, then quarterly thereafter. Your lung function will also be periodically assessed to track your response to the medication.
Protecting your irreplaceable lung function is crucial to managing this disease. Therefore, consistently taking Pulmofib 801mg Tablet, as directed by your doctor, is strongly recommended to help maintain your current lung capacity.
Pulmofib 801mg Tablet may cause sun sensitivity, nausea, fatigue, diarrhea, indigestion, loss of appetite, and headache. Other possible side effects include upper respiratory and bladder infections, weight loss, insomnia, dizziness, drowsiness, altered taste, hot flashes, shortness of breath, and cough. Gastrointestinal issues like acid reflux, vomiting, bloating, abdominal pain, heartburn, and constipation may also occur. Skin reactions such as itching, redness, dryness, and rash are possible, as are muscle pain, joint pain, weakness, chest pain, and sunburn. Elevated liver enzymes may be detected in blood tests.
Pulmofib 801mg tablets are not steroids; they're pyridines. Prescribed for adults with idiopathic pulmonary fibrosis (IPF), they help manage the scarring and swelling in lung tissue that hinders breathing. This reduces breathing difficulties.
You and your doctor must determine if Pulmofib 801mg Tablet is appropriate for you. Your doctor will prescribe it only after evaluating your condition. Continued use depends on your response and tolerance to the medication.
Idiopathic pulmonary fibrosis progresses unpredictably. Never discontinue Pulmofib 801mg Tablet without your doctor's advice. Continued use may help slow disease progression.
Minimize sun exposure while taking Pulmofib 801mg Tablet. Daily sunscreen use and covering exposed skin are recommended. Avoid smoking, as it can reduce the medication's effectiveness.
While the average lifespan for pulmonary fibrosis patients is two to three years, some individuals survive significantly longer. Reduced survival is associated with older age, smoking, and lower BMI. Further contributing factors include advanced disease severity (radiologically and functionally) and the occurrence of additional lung problems.
Pulmofib 801mg Tablet
626
MRP 725
13% off